Document Detail


Initial clinical experience with contrast-enhanced digital breast tomosynthesis.
MedLine Citation:
PMID:  17236995     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE AND OBJECTIVES: Contrast-enhanced digital mammography and digital breast tomosynthesis are two imaging techniques that attempt to increase malignant breast lesion conspicuity. The combination of these into a single technique, contrast-enhanced digital breast tomosynthesis (CE-DBT), could potentially integrate the strengths of both. The objectives of this study were to assess the clinical feasibility of CE-DBT as an adjunct to digital mammography, and to correlate lesion enhancement characteristics and morphology obtained with CE-DBT to digital mammography, ultrasound, and magnetic resonance (MR). MATERIALS AND METHODS: CE-DBT (GE Senographe 2000D; Milwaukee, WI) was performed as a pilot study in an ongoing National Cancer Institute-funded grant (P01-CA85484) studying multimodality breast imaging. Thirteen patients with ACR BI-RADS category 4 or 5 breast lesions underwent imaging with digital mammography, ultrasound, MR, and CE-DBT. CE-DBT was performed at 49 kVp with a rhodium target and a 0.27-mm copper (Alfa Aesar, Ward Hill, MA) filter. Preinjection and postinjection DBT image sets were acquired in the medial lateral oblique projection with slight compression. Each image set consists of nine images acquired over a 50-degree arc and was obtained with a mean glandular x-ray dose comparable to two conventional mammographic views. Between the precontrast and postcontrast DBT image sets, a single bolus of iodinated contrast agent (1 ml/kg at 2 ml/s, Omnipaque-300; Amersham Health Inc., Princeton, NJ) was administered. Images were reconstructed using filtered-backprojection in 1-mm increments and transmitted to a clinical PACS workstation. RESULTS: Initial experience suggests that CE-DBT provides morphologic and vascular characteristics of breast lesions qualitatively concordant with that of digital mammography and MR. CONCLUSION: As an adjunct to digital mammography, CE-DBT may be a potential alternative tool for breast lesion morphologic and vascular characterization.
Authors:
Sara C Chen; Ann-Katherine Carton; Michael Albert; Emily F Conant; Mitchell D Schnall; Andrew D A Maidment
Related Documents :
12773685 - Breast lesions detected with mr imaging: utility and histopathologic importance of iden...
18024435 - Meta-analysis of mr imaging in the diagnosis of breast lesions.
20972855 - Comparison of magnetic resonance imaging and multidetector computed tomography for eval...
7484475 - Residual silicone detection using mri following previous breast implant removal: case r...
18072475 - Reduction of a grid moiré pattern by integrating a carbon-interspaced high precision x...
16568195 - New diagnostic and treatment modalities for pulmonary embolism: one path through the co...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Academic radiology     Volume:  14     ISSN:  1076-6332     ISO Abbreviation:  Acad Radiol     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-22     Completed Date:  2007-04-03     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  9440159     Medline TA:  Acad Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  229-38     Citation Subset:  IM    
Affiliation:
Department of Radiology, Hospital of the University of Pennsylvania, 1 Silverstein, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Breast Neoplasms / radiography*
Contrast Media
Humans
Mammography
Middle Aged
Neovascularization, Pathologic / radiography*
Pilot Projects
Radiographic Image Enhancement / instrumentation*
Radiographic Image Interpretation, Computer-Assisted
Tomography / instrumentation*
Triiodobenzoic Acids / diagnostic use
Grant Support
ID/Acronym/Agency:
P01 CA085424-01A2/CA/NCI NIH HHS; P01-CA85484/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Triiodobenzoic Acids; 92339-11-2/iodixanol
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Initial clinical experience with microwave breast imaging in women with normal mammography.
Next Document:  A quality assurance elective for radiology residents.